Results 281 to 281 of about 515,791 (281)

Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial

Nature Medicine
Xavier Leleu, Aurore Perrot, Jill Corre
exaly